About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2010 (2010), Article ID 170432, 13 pages
http://dx.doi.org/10.1155/2010/170432
Review Article

Current Hypotheses on How Microsatellite Instability Leads to Enhanced Survival of Lynch Syndrome Patients

1Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178, USA
2Department of Pathology, Creighton University School of Medicine, Omaha, NE 68178, USA
3Department of Preventative Medicine, Creighton University School of Medicine, Omaha, NE 68178, USA

Received 8 January 2010; Accepted 13 April 2010

Academic Editor: C. Pauza

Copyright © 2010 Kristen M. Drescher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Warthin, “Hereditary with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895–1913,” Archives of Internal Medicine, vol. 12, pp. 546–555, 1913.
  2. H. T. Lynch, M. W. Shaw, C. W. Magnuson, A. L. Larsen, and A. J. Krush, “Hereditary factors in cancer. Study of two large midwestern kindreds,” Archives of Internal Medicine, vol. 117, no. 2, pp. 206–212, 1966. View at Publisher · View at Google Scholar · View at Scopus
  3. H. T. Lynch and A. J. Krush, “Cancer family "G" revisited: 1895–1970,” Cancer, vol. 27, no. 6, pp. 1505–1511, 1971. View at Scopus
  4. S. N. Thibodeau, G. Bren, and D. Schaid, “Microsatellite instability in cancer of the proximal colon,” Science, vol. 260, no. 5109, pp. 816–819, 1993. View at Scopus
  5. Y. Ionov, M. A. Peinado, S. Malkhosyan, D. Shibata, and M. Perucho, “Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis,” Nature, vol. 363, no. 6429, pp. 558–561, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. Aaltonen, P. Peltomaki, F. S. Leach et al., “Clues to the pathogenesis of familial colorectal cancer,” Science, vol. 260, no. 5109, pp. 812–816, 1993. View at Scopus
  7. R. H. Sijmons, L. A. L. M. Kiemeney, J. A. Witjes, and H. F. A. Vasen, “Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options,” Journal of Urology, vol. 160, no. 2, pp. 466–470, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Aarnio, J.-P. Mecklin, L. A. Aaltonen, M. Nystrom-Lahti, and H. J. Jarvinen, “Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome,” International Journal of Cancer, vol. 64, no. 6, pp. 430–433, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Watson, H. F. A. Vasen, J. P. Mecklin, H. Järvinen, and H. T. Lynch, “The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer,” American Journal of Medicine, vol. 96, no. 6, pp. 516–520, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Watson, H. F. A. Vasen, J.-P. Mecklin et al., “The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome,” International Journal of Cancer, vol. 123, no. 2, pp. 444–449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Watson, K. M. Lin, M. A. Rodriguez-Bigas et al., “Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members,” Cancer, vol. 83, no. 2, pp. 259–266, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. H. F. A. Vasen, G. J. A. Offerhaus, F. C. A. den Hartog Jager et al., “The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in The Netherlands,” International Journal of Cancer, vol. 46, no. 1, pp. 31–34, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Watson and H. T. Lynch, “Extracolonic cancer in hereditary nonpolyposis colorectal cancer,” Cancer, vol. 71, no. 3, pp. 677–685, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. H. F. A. Vasen, J. T. Wijnen, F. H. Menko et al., “Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis,” Gastroenterology, vol. 110, no. 4, pp. 1020–1027, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. H. F. A. Vasen, E. A. C. M. Sanders, B. G. Taal et al., “The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC),” International Journal of Cancer, vol. 65, no. 4, pp. 422–425, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. H. F. A. Vasen, H. Morreau, and J. W. R. Nortier, “Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?” American Journal of Human Genetics, vol. 68, no. 6, pp. 1533–1535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Boyd, E. Rhei, M. G. Federici et al., “Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome,” Breast Cancer Research and Treatment, vol. 53, no. 1, pp. 87–91, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Kinoshita, A. Yanagisawa, T. Watanabe et al., “Increase in the frequency of K-ras codon 12 point mutation in colorectal carcinoma in elderly males in Japan: the 1990s compared with the 1960s,” Cancer Science, vol. 96, no. 4, pp. 218–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-T. Liang, Y.-M. Cheng, K.-J. Chang, C.-T. Chien, and H. C. Hsu, “Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection,” Hepato-Gastroenterology, vol. 46, no. 26, pp. 830–837, 1999. View at Scopus
  20. T. Enomoto, M. Fujita, M. Inoue et al., “Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium,” Cancer Research, vol. 53, no. 8, pp. 1883–1888, 1993. View at Scopus
  21. R. J. C. Slebos, R. E. Kibbelaar, O. Dalesio et al., “K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung,” New England Journal of Medicine, vol. 323, no. 9, pp. 561–565, 1990. View at Scopus
  22. D. Shibata, G. Capella, and M. Perucho, “Mutational activation of the c-K-ras gene in human pancreatic carcinoma,” Bailliere's Clinical Gastroenterology, vol. 4, no. 1, pp. 151–169, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. V. K. Shukla, D. C. Hughes, L. E. Hughes, F. McCormick, and R. A. Padua, “ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development,” Oncogene Research, vol. 5, no. 2, pp. 121–127, 1989. View at Scopus
  24. E. R. Fearon and B. Vogelstein, “A genetic model for colorectal tumorigenesis,” Cell, vol. 61, no. 5, pp. 759–767, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Yamamoto, H. Sawai, T. K. Weber, M. A. Rodriguez-Bigas, and M. Perucho, “Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer,” Cancer Research, vol. 58, no. 5, pp. 997–1003, 1998. View at Scopus
  26. L. Losi, M. Ponz de Leon, J. Jiricny et al., “K-ras and p53 mutations in hereditary non-polyposis colorectal cancers,” International Journal of Cancer, vol. 74, no. 1, pp. 94–96, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. M. C. Hendriks, A. E. de Jong, H. Morreau et al., “Diagnostic approach and management of Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): a guide for clinicians,” CA: A Cancer Journal for Clinicians, vol. 56, no. 4, pp. 213–225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Graham and H. D. Appelman, “Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator,” Modern Pathology, vol. 3, no. 3, pp. 332–335, 1990. View at Scopus
  29. S. Popat, R. Hubner, and R. S. Houlston, “Systematic review of microsatellite instability and colorectal cancer prognosis,” Journal of Clinical Oncology, vol. 23, no. 3, pp. 609–618, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Dolcetti, A. Viel, C. Doglioni et al., “High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability,” American Journal of Pathology, vol. 154, no. 6, pp. 1805–1813, 1999. View at Scopus
  31. K. M. Drescher, P. Sharma, P. Watson, Z. Gatalica, S. N. Thibodeau, and H. T. Lynch, “Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer,” Familial Cancer, vol. 8, no. 3, pp. 231–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. W. Bennett, J. O'Connell, G. C. O'Sullivan et al., “The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma,” Journal of Immunology, vol. 160, no. 11, pp. 5669–5675, 1998. View at Scopus
  33. B. Fisk, B. W. Anderson, K. R. Gravitt et al., “Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes,” Cancer Research, vol. 57, no. 1, pp. 87–93, 1997. View at Scopus
  34. R. Sankila, L. A. Aaltonen, H. J. Jarvinen, and J.-P. Mecklin, “Better survival rates in patients with MLH1-associated hereditary colorectal cancer,” Gastroenterology, vol. 110, no. 3, pp. 682–687, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Rhyu, “Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma,” Journal of the National Cancer Institute, vol. 88, no. 5, pp. 240–251, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. J. V. Frei, “Hereditary nonpolyposis colorectal cancer (Lynch syndrome II): diploid malignancies with prolonged survival,” Cancer, vol. 69, no. 5, pp. 1108–1111, 1992. View at Scopus
  37. M. Kouri, A. Laasonen, J.-P. Mecklin, H. Jarvinen, K. Franssila, and S. Pyrhonen, “Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry,” Cancer, vol. 65, no. 8, pp. 1825–1829, 1990. View at Scopus
  38. E. J. Foley, “Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin,” Cancer Research, vol. 13, pp. 835–837, 1953.
  39. D. Murray, A. Hreno, J. Dutton, and L. G. Hampson, “Prognosis in colon cancer. A pathologic reassessment,” Archives of Surgery, vol. 110, no. 8, pp. 908–913, 1975. View at Scopus
  40. B. Mann, A. Gratchev, C. Böhm et al., “FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas,” British Journal of Cancer, vol. 79, no. 7-8, pp. 1262–1269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Buckowitz, H.-P. Knaebel, A. Benner et al., “Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases,” British Journal of Cancer, vol. 92, no. 9, pp. 1746–1753, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Le Gouvello, S. Bastuji-Garin, N. Aloulou et al., “High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas,” Gut, vol. 57, no. 6, pp. 772–779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Morris, C. Platell, and B. Iacopetta, “Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy,” Clinical Cancer Research, vol. 14, no. 5, pp. 1413–1417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. W. Bennett, J. O'Connell, G. C. O'Sullivan et al., “Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer,” Gut, vol. 44, no. 2, pp. 156–162, 1999. View at Scopus
  45. K. Okada, K. Komuta, S. Hashimoto, S. Matsuzaki, T. Kanematsu, and T. Koji, “Frequency of apoptosis of tumor-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis,” Clinical Cancer Research, vol. 6, no. 9, pp. 3560–3564, 2000. View at Scopus
  46. K. Okano, T. Maeba, A. Moroguchi et al., “Lymphocytic infiltration surrounding liver metastases from colorectal cancer,” Journal of Surgical Oncology, vol. 82, no. 1, pp. 28–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. T. C. Smyrk, P. Watson, K. Kaul, and H. T. Lynch, “Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma,” Cancer, vol. 91, no. 12, pp. 2417–2422, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Prall, T. Dührkop, V. Weirich et al., “Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability,” Human Pathology, vol. 35, no. 7, pp. 808–816, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. A. G. Menon, C. M. Janssen-van Rhijn, H. Morreau et al., “Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis,” Laboratory Investigation, vol. 84, no. 4, pp. 493–501, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Pagès, A. Kirilovsky, B. Mlecnik et al., “In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer,” Journal of Clinical Oncology, vol. 27, no. 35, pp. 5944–5951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. H. T. Lynch and A. de la Chapelle, “Hereditary colorectal cancer,” New England Journal of Medicine, vol. 348, no. 10, pp. 919–932, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Hampel, W. L. Frankel, E. Martin et al., “Feasibility of screening for Lynch syndrome among patients with colorectal cancer,” Journal of Clinical Oncology, vol. 26, no. 35, pp. 5783–5788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. L. A. Aaltonen, R. Salovaara, P. Kristo et al., “Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease,” New England Journal of Medicine, vol. 338, no. 21, pp. 1481–1487, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Wijnen, W. De Leeuw, H. Vasen et al., “Familial endometrial cancer in female carriers of MSH6 germline mutations,” Nature Genetics, vol. 23, no. 2, pp. 142–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. J. M. Cunningham, E. R. Christensen, D. J. Tester et al., “Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability,” Cancer Research, vol. 58, no. 15, pp. 3455–3460, 1998. View at Scopus
  56. S. A. Kuismanen, M. T. Holmberg, R. Salovaara, A. de la Chapell, and P. Peltomaki, “Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers,” American Journal of Pathology, vol. 156, no. 5, pp. 1773–1779, 2000. View at Scopus
  57. J. G. Herman, A. Umar, K. Polyak et al., “Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 6870–6875, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. M. L. Veigl, L. Kasturi, J. Olechnowicz et al., “Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8698–8702, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Mueller-Koch, H. Vogelsang, R. Kopp et al., “Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer,” Gut, vol. 54, no. 12, pp. 1733–1740, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. N. M. Lindor, K. Rabe, G. M. Petersen et al., “Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X,” Journal of the American Medical Association, vol. 293, no. 16, pp. 1979–1985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Jover, P. Zapater, A. Castells et al., “The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status,” European Journal of Cancer, vol. 45, no. 3, pp. 365–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. H. F. A. Vasen, J.-P. Mecklin, P. Meera Khan, and H. T. Lynch, “The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC),” Diseases of the Colon and Rectum, vol. 34, no. 5, pp. 424–425, 1991. View at Scopus
  63. P. Gervaz, P. Bucher, and P. Morel, “Two colons-two cancers: paradigm shift and clinical implications,” Journal of Surgical Oncology, vol. 88, no. 4, pp. 261–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. H. F. A. Vasen, “Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)],” Familial Cancer, vol. 4, no. 3, pp. 219–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. H. T. Lynch and A. de la Chapelle, “Genetic susceptibility to non-polyposis colorectal cancer,” Journal of Medical Genetics, vol. 36, no. 11, pp. 801–818, 1999. View at Scopus
  66. D. W. Voskuil, H. F. A. Vasen, E. Kampman, and P. van't Veer, “Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations,” International Journal of Cancer, vol. 72, no. 2, pp. 205–209, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Aarnio, R. Sankila, E. Pukkala et al., “Cancer risk in mutation carriers of DNA-mismatch-repair genes,” International Journal of Cancer, vol. 81, no. 2, pp. 214–218, 1999. View at Scopus
  68. H. Fredriksson, T. Ikonen, V. Autio et al., “Identification of germline MLH1 alterations in familial prostate cancer,” European Journal of Cancer, vol. 42, no. 16, pp. 2802–2806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. H. T. Lynch, P. M. Lynch, S. J. Lanspa, C. L. Snyder, J. F. Lynch, and C. R. Boland, “Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications,” Clinical Genetics, vol. 76, no. 1, pp. 1–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. K. M. Lin, M. Shashidharan, A. G. Thorson et al., “Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer,” Journal of Gastrointestinal Surgery, vol. 2, no. 1, pp. 67–71, 1998. View at Scopus
  71. H. F. A. Vasen, A. Stormorken, F. H. Menko et al., “MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families,” Journal of Clinical Oncology, vol. 19, no. 20, pp. 4074–4080, 2001. View at Scopus
  72. H. Hampel, J. A. Stephens, E. Pukkala et al., “Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset,” Gastroenterology, vol. 129, no. 2, pp. 415–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Quehenberger, H. F. A. Vasen, and H. C. van Houwelingen, “Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment,” Journal of Medical Genetics, vol. 42, no. 6, pp. 491–496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Carayol, M. Khlat, J. Maccario, and C. Bonaïti-Pellié, “Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated,” Journal of Medical Genetics, vol. 39, no. 5, pp. 335–339, 2002. View at Scopus
  75. J. Plaschke, C. Engel, S. Kruger, et al., “Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome,” Journal of Clinical Oncology, vol. 22, pp. 4486–4494, 2004.
  76. E. Barrow, L. Robinson, W. Alduaij et al., “Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations,” Clinical Genetics, vol. 75, no. 2, pp. 141–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. H. T. Lynch, T. Smyrk, and J. R. Jass, “Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas?” Seminars in Surgical Oncology, vol. 11, no. 6, pp. 406–410, 1995. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Mecklin, M. Aarnio, E. Läärä et al., “Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome,” Gastroenterology, vol. 133, no. 4, pp. 1093–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. F. E. M. Rijcken, H. Hollema, and J. H. Kleibeuker, “Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation,” Gut, vol. 50, no. 3, pp. 382–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Watanabe, T. Muto, T. Sawada, and M. Miyaki, “Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma,” Cancer, vol. 77, no. 4, pp. 627–634, 1996. View at Publisher · View at Google Scholar · View at Scopus
  81. H. T. Lynch, T. Smyrk, T. McGinn et al., “Attenuated familial adenomatous polyposis (AFAP): a phenotypically and genotypically distinctive variant of FAP,” Cancer, vol. 76, no. 12, pp. 2427–2433, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Cao, M. Pieretti, J. Marshall et al., “Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature,” American Journal of Gastroenterology, vol. 97, no. 7, pp. 1822–1827, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. A. E. de Jong, H. Morreau, M. van Puijenbroek et al., “The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC,” Gastroenterology, vol. 126, no. 1, pp. 42–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Giuffrè, A. Müller, T. Brodegger et al., “Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis,” Journal of Molecular Diagnostics, vol. 7, no. 2, pp. 160–170, 2005. View at Scopus
  85. B. Halvarsson, A. Lindblom, L. Johansson, K. Lagerstedt, and M. Nilbert, “Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer,” Modern Pathology, vol. 18, no. 8, pp. 1095–1101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Iino, L. Simms, J. Young et al., “DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer,” Gut, vol. 47, no. 1, pp. 37–42, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Müller, C. Beckmann, G. Westphal et al., “Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study,” International Journal of Colorectal Disease, vol. 21, no. 7, pp. 632–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. M. S. Pino, M. Mino-Kenudson, B. M. Wildemore et al., “Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas,” Journal of Molecular Diagnostics, vol. 11, no. 3, pp. 238–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. J. R. Jass and S. M. Stewart, “Evolution of hereditary non-polyposis colorectal cancer,” Gut, vol. 33, no. 6, pp. 783–786, 1992. View at Scopus
  90. H. J. Järvinen, M. Aarnio, H. Mustonen et al., “Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer,” Gastroenterology, vol. 118, no. 5, pp. 829–834, 2000. View at Scopus
  91. P. M. Johnson, S. Gallinger, and R. S. McLeod, “Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review,” Diseases of the Colon and Rectum, vol. 49, no. 1, pp. 80–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. G. Lindgren, A. Liljegren, E. Jaramillo, C. Rubio, and A. Lindblom, “Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer,” Gut, vol. 50, no. 2, pp. 228–234, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. N. M. Lindor, G. M. Petersen, D. W. Hadley et al., “Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review,” Journal of the American Medical Association, vol. 296, no. 12, pp. 1507–1517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Kloor, C. Becker, A. Benner et al., “Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers,” Cancer Research, vol. 65, no. 14, pp. 6418–6424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. H. F. A. Vasen, B. G. Taal, F. M. Nagengast et al., “Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families,” European Journal of Cancer A, vol. 31, no. 7-8, pp. 1145–1148, 1995. View at Publisher · View at Google Scholar · View at Scopus
  96. S. J. Lanspa, J. X. Jenkins, R. J. Cavalieri et al., “Surveillance in Lynch syndrome: how aggressive?” American Journal of Gastroenterology, vol. 89, no. 11, pp. 1978–1980, 1994. View at Scopus
  97. H. J. Järvinen, J.-P. Mecklin, and P. Sistonen, “Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer,” Gastroenterology, vol. 108, no. 5, pp. 1405–1411, 1995. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Muto, H. J. R. Bussey, and B. C. Morson, “The evolution of cancer of the colon and rectum,” Cancer, vol. 36, no. 6, pp. 2251–2270, 1975. View at Scopus
  99. R. Gryfe, H. Kim, E. T. K. Hsieh et al., “Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer,” New England Journal of Medicine, vol. 342, no. 2, pp. 69–77, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. V. Stigliano, D. Assisi, M. Cosimelli et al., “Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients,” Journal of Experimental and Clinical Cancer Research, vol. 27, no. 1, article 39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. C. M. Kets, N. Hoogerbrugge, D. Bodmer et al., “Unfavorable pathological characteristics in familial colorectal cancer with low-level microsatellite instability,” Modern Pathology, vol. 19, no. 12, pp. 1624–1630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Waldner, C. C. Schimanski, and M. F. Neurath, “Colon cancer and the immune system: the role of tumor invading T cells,” World Journal of Gastroenterology, vol. 12, no. 45, pp. 7233–7238, 2006. View at Scopus
  103. M. Numasaki, J.-I. Fukushi, M. Ono et al., “Interleukin-17 promotes angiogenesis and tumor growth,” Blood, vol. 101, no. 7, pp. 2620–2627, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. E. Tartour, F. Fossiez, I. Joyeux et al., “Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice,” Cancer Research, vol. 59, no. 15, pp. 3698–3704, 1999. View at Scopus
  105. C. Loddenkemper, M. Schernus, M. Noutsias, H. Stein, E. Thiel, and D. Nagorsen, “In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer,” Journal of Translational Medicine, vol. 4, pp. 52–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. A. D. Polydorides, B. Mukherjee, S. B. Gruber, B. J. McKenna, H. D. Appelman, and J. K. Greenson, “Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer,” The American journal of Surgical Pathology, vol. 32, no. 11, pp. 1661–1666, 2008. View at Scopus
  107. M. Strand, T. A. Prolla, R. M. Liskay, and T. D. Petes, “Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair,” Nature, vol. 365, no. 6443, pp. 274–276, 1993. View at Publisher · View at Google Scholar · View at Scopus
  108. D. Shibata, M. A. Peinado, Y. Ionov, S. Malkhosyan, and M. Perucho, “Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation,” Nature Genetics, vol. 6, no. 3, pp. 273–281, 1994. View at Publisher · View at Google Scholar · View at Scopus
  109. N. P. Bhattacharyya, A. Skandalis, A. Ganesh, J. Groden, and M. Meuth, “Mutator phenotypes in human colorectal carcinoma cell lines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 14, pp. 6319–6323, 1994. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Parsons, G.-M. Li, M. J. Longley et al., “Hypermutability and mismatch repair deficiency in RER+ tumor cells,” Cell, vol. 75, no. 6, pp. 1227–1236, 1993. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. Akiyama, H. Sato, T. Yamada et al., “Germ-line mutation of the hmSH6/GTPB gene in an atypical hereditary nonpolyposis colerectal cancer kindred,” Cancer Research, vol. 57, no. 18, pp. 3920–3923, 1997. View at Scopus
  112. C. E. Bronner, S. M. Baker, P. T. Morrison et al., “Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer,” Nature, vol. 368, no. 6468, pp. 258–261, 1994. View at Publisher · View at Google Scholar · View at Scopus
  113. F. S. Leach, N. C. Nicolaides, N. Papadopoulos et al., “Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer,” Cell, vol. 75, no. 6, pp. 1215–1225, 1993. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Miyaki, M. Konishi, K. Tanaka et al., “Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer,” Nature Genetics, vol. 17, no. 3, pp. 271–272, 1997. View at Scopus
  115. N. C. Nicolaldes, N. Papadopoulos, B. Liu et al., “Mutations of two PMS homologues in hereditary nonpolyposis colon cancer,” Nature, vol. 371, no. 6492, pp. 75–80, 1994. View at Publisher · View at Google Scholar · View at Scopus
  116. N. Papadopoulos, N. C. Nicolaides, Y.-F. Wei et al., “Mutation of a mutL homolog in hereditary colon cancer,” Science, vol. 263, no. 5153, pp. 1625–1629, 1994. View at Scopus
  117. Y. Akiyama, N. Tsubouchi, and Y. Yuasa, “Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers,” Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 248–252, 1997. View at Publisher · View at Google Scholar · View at Scopus
  118. S. M. Lipkin, V. Wang, R. Jacoby et al., “MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability,” Nature Genetics, vol. 24, no. 1, pp. 27–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  119. T. A. Kunkel and D. A. Erie, “DNA mismatch repair,” Annual Review of Biochemistry, vol. 74, pp. 681–710, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. T. Jascur and C. R. Boland, “Structure and function of the components of the human DNA mismatch repair system,” International Journal of Cancer, vol. 119, no. 9, pp. 2030–2035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. T. Pal, J. Permuth-Wey, and T. A. Sellers, “A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer,” Cancer, vol. 113, no. 4, pp. 733–742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Duval and R. Hamelin, “Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability,” Cancer Research, vol. 62, no. 9, pp. 2447–2454, 2002. View at Scopus
  123. P. Peltomaki, H. F. A. Vasen, M.-L. Bisgaard et al., “Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study,” Gastroenterology, vol. 113, no. 4, pp. 1146–1158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  124. J. Huang, S. A. Kuismanen, T. Liu et al., “MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer,” Cancer Research, vol. 61, no. 4, pp. 1619–1623, 2001. View at Scopus
  125. A. E. de Jong, M. van Puijenbroek, Y. Hendriks et al., “Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer,” Clinical Cancer Research, vol. 10, no. 3, pp. 972–980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  126. B. Halvarsson, A. Lindblom, E. Rambech, K. Lagerstedt, and M. Nilbert, “The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer,” Familial Cancer, vol. 5, no. 4, pp. 353–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. Y. M. C. Hendriks, S. Jagmohan-Changur, H. M. van der Klift et al., “Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome),” Gastroenterology, vol. 130, no. 2, pp. 312–322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Ignatowicz, J. Kappler, and P. Marrack, “The repertoire of T cells shaped by a single MHC/peptide ligand,” Cell, vol. 84, no. 4, pp. 521–529, 1996. View at Publisher · View at Google Scholar · View at Scopus
  129. G. J. V. Nossal, “Negative selection of lymphocytes,” Cell, vol. 76, no. 2, pp. 229–239, 1994. View at Publisher · View at Google Scholar · View at Scopus
  130. J. W. Kappler, N. Roehm, and P. Marrack, “T cell tolerance by clonal elimination in the thymus,” Cell, vol. 49, no. 2, pp. 273–280, 1987. View at Scopus
  131. A. V. Pisarchik and N. A. Kartel, “Simple repetitive sequences and gene expression,” Molecular Biology, vol. 34, no. 3, pp. 303–307, 2000. View at Scopus
  132. Y. Mori, J. Yin, A. Rashid et al., “Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability,” Cancer Research, vol. 61, no. 16, pp. 6046–6049, 2001. View at Scopus
  133. C. R. Boland, S. N. Thibodeau, S. R. Hamilton et al., “A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer,” Cancer Research, vol. 58, no. 22, pp. 5248–5257, 1998. View at Scopus
  134. M. Linnebacher, J. Gebert, W. Rudy et al., “Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens,” International Journal of Cancer, vol. 93, no. 1, pp. 6–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  135. S. M. Woerner, J. Gebert, Y. P. Yuan et al., “Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells,” International Journal of Cancer, vol. 93, no. 1, pp. 12–19, 2001. View at Publisher · View at Google Scholar · View at Scopus
  136. I. Sæterdal, J. Bjørheim, K. Lislerud et al., “Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 13255–13260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  137. Y. Schwitalle, M. Kloor, S. Eiermann et al., “Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers,” Gastroenterology, vol. 134, no. 4, pp. 988–997, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Kloor, S. Michel, B. Buckowitz et al., “β2-microglobulin mutations in microsatellite unstable colorectal tumors,” International Journal of Cancer, vol. 121, no. 2, pp. 454–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  139. D. C. Bicknell, L. Kaklamanis, R. Hampson, W. F. Bodmer, and P. Karran, “Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas,” Current Biology, vol. 6, no. 12, pp. 1695–1697, 1996. View at Scopus
  140. C. M. Cabrera, P. Jiménez, T. Cabrera, C. Esparza, F. Ruiz-Cabello, and F. Garrido, “Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors,” Tissue Antigens, vol. 61, no. 3, pp. 211–219, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. R. L. Ferris, T. L. Whiteside, and S. Ferrone, “Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer,” Clinical Cancer Research, vol. 12, no. 13, pp. 3890–3895, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. B. Seliger, D. Atkins, M. Bock et al., “Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation,” Clinical Cancer Research, vol. 9, no. 5, pp. 1721–1727, 2003. View at Scopus
  143. J. W. F. Dierssen, N. F. C. C. de Miranda, S. Ferrone et al., “HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression,” BMC Cancer, vol. 7, pp. 32–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. C. M. Ribic, D. J. Sargent, M. J. Moore et al., “Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer,” New England Journal of Medicine, vol. 349, no. 3, pp. 247–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. L. Roncucci, E. Mora, F. Mariani et al., “Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2291–2297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. F. A. Sinicrope, R. L. Rego, M. M. Garrity-Park et al., “Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability,” International Journal of Cancer, vol. 120, no. 6, pp. 1232–1238, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. J. O'Connell, G. C. O'Sullivan, J. K. Collins, and F. Shanahan, “The Fas counterattack: fas-mediated T cell killing by colon cancer expressing Fas ligand,” Journal of Experimental Medicine, vol. 184, no. 3, pp. 1075–1082, 1996. View at Scopus
  148. J. J. Koornstra, S. de Jong, W. Boersma-van Eck et al., “Fas ligand expression in lynch syndrome-associated colorectal tumours,” Pathology and Oncology Research, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. H. F. A. Vasen, G. Möslein, A. Alonso et al., “Recommendations to improve identification of hereditary and familial colorectal cancer in Europe,” Familial Cancer, vol. 9, no. 2, pp. 109–115, 2009. View at Publisher · View at Google Scholar
  150. I. Zighelboim, M. A. Powell, S. A. Babb et al., “Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome,” Familial Cancer, vol. 8, no. 4, pp. 501–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. L. Zhang, “Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part II. The utility of microsatellite instability testing,” Journal of Molecular Diagnostics, vol. 10, no. 4, pp. 301–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. J. Shia, “Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. The utility of immunohistochemistry,” Journal of Molecular Diagnostics, vol. 10, no. 4, pp. 293–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  153. J. T. Wijnen, R. M. Brohet, R. van Eijk et al., “Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome,” Gastroenterology, vol. 136, no. 1, pp. 131–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. A. Banerjea, S. Ahmed, R. E. Hands et al., “Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity,” Molecular Cancer, vol. 3, pp. 21–32, 2004. View at Publisher · View at Google Scholar · View at Scopus